Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Preferred Stock Liabilities (2020)

Historic Preferred Stock Liabilities for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to $45.4 million.

  • Design Therapeutics' Preferred Stock Liabilities changed N/A to $45.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $45.4 million, marking a year-over-year change of. This contributed to the annual value of $45.4 million for FY2020, which is N/A changed from last year.
  • Per Design Therapeutics' latest filing, its Preferred Stock Liabilities stood at $45.4 million for Q4 2020.
  • Over the past 5 years, Design Therapeutics' Preferred Stock Liabilities peaked at $45.4 million during Q4 2020, and registered a low of $45.4 million during Q4 2020.